PER-050-12未知未知
acetyl cysteine ​​and ACETAZOLAMIDE FOR THE TREATMENT OF CHRONIC MOUNTAIN SICKNESS IN SETTLERS OF HIGHLANDS OF THE PERUVIAN ANDES
Thomas H Maren Foundation,0 个研究点目标入组 0 人开始时间: 2012年10月9日最近更新:
试验速览
- 阶段
- 未知
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- Male
入选标准
- •MALE SUBJECT (WOMEN WILL BE EXCLUDED TO AVOID MENSTRUAL PROBLEMS)
- •AGE: 18 YEARS OR MORE.
- •HEMATOCRIT> 65%.
- •MMC SCORE> 6 (ANNEX 1). SCORE IS 0-3 IN THE PRESENCE OF 10 FEATURES INCLUDING: HEADACHE, DIZZINESS, MENTAL WEAKNESS, MENTAL FATIGUE, Dyspnea, INSOMNIA, TINNITUS, ANOREXIA, CYANOSIS, AND conjunctival hyperemia (1).
排除标准
- •PREVIOUS HISTORY OF ALLERGY / ADVERSE REACTION TO ACTZ OR NAC
- •SMOKING CIGARETTES OVER 5 / DAY.
- •PHLEBOTOMY IN THREE MONTHS PRIOR TO THE STUDY.
- •SERUM POTASSIUM < 3.5 MEQ / L
- •SERUM SODIUM <128 MEQ / L
- •SCORE MMC > 15
- •PULMONARY DISEASE, ASTHMA INCLUDING, WITH THE REQUIREMENT OF USE OF OXYGEN.
- •Cirrhosis
- •ADRENAL FAILURE
- •Aspirin CONSUMPTION> 1 GR / DAY
- •CONTRAINDICATIONS FOR ARTERIAL BLOOD SAMPLING FROM RADIAL ARTERY.
研究者
相似试验
尚未招募
不适用
Acetylcysteïne Dosing in acute PARacetamol intoxicatioAcute paracetamol intoxicationNL-OMON22271MCG2,000
尚未招募
Unknown
AC for treatment of Obsessive-Compulsive DisorderObsessive-compulsive disorderObsessive-compulsive disorder.IRCT20170123032145N7Iran University of Medical Sciences44
尚未招募
4 期
Safety And Efficacy of Abiways In Moderate to Severe Asthma And COPD Patients.CTRI/2023/06/053647Mankind Pharma
已完成
2 期
Adjuvant N Acetylcysteine for Post Traumatuic Stress DisorderACTRN12618001784202Austin Health105
尚未招募
4 期
acetylcysteine to improve neurological outcomes in neonates with hypoxic ischemic encephalopathyCTRI/2021/03/031798Jawaharlal Institute of Postgraduate Medical Education and Research